Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Cipla
Citi
Farmers Insurance
Daiichi Sankyo
Teva
US Army
McKinsey
Chubb

Generated: October 23, 2017

DrugPatentWatch Database Preview

XENICAL Drug Profile

« Back to Dashboard

Which patents cover Xenical, and what generic Xenical alternatives are available?

Xenical is a drug marketed by Hoffmann La Roche and is included in one NDA. There is one patent protecting this drug.

This drug has forty patent family members in thirty-three countries and two supplementary protection certificates in two countries.

The generic ingredient in XENICAL is orlistat. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the orlistat profile page.

Summary for Tradename: XENICAL

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list58
Clinical Trials: see list15
Patent Applications: see list6,122
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:XENICAL at DailyMed

Pharmacology for Tradename: XENICAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann La Roche
XENICAL
orlistat
CAPSULE;ORAL020766-001Apr 23, 1999RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: XENICAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hoffmann La Roche
XENICAL
orlistat
CAPSULE;ORAL020766-001Apr 23, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: XENICAL

Country Document Number Estimated Expiration
Cyprus2264► Subscribe
Poland330972► Subscribe
Taiwan533082► Subscribe
Colombia4920214► Subscribe
Hungary0001468► Subscribe
Yugoslavia49698► Subscribe
China1220600► Subscribe
Denmark0921796► Subscribe
Norway985337► Subscribe
Peru57599► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: XENICAL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0042Belgium► SubscribePRODUCT NAME: ORLISTAT; REGISTRATION NO/DATE: EU/1/98/071/001 19980729
C/GB98/044United Kingdom► SubscribePRODUCT NAME: ORLISTAT; REGISTERED: UK EU/1/98/071/001 19980729; UK EU/1/98/071/002 19980729; UK EU/1/98/071/003 19980729; UK EO/1/98/071/004 19980729; UK EU/1/98/071/005 19980729; UK EU/1/98/071/006 19980729
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Mallinckrodt
Cerilliant
Argus Health
US Department of Justice
Daiichi Sankyo
AstraZeneca
Cipla
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot